Apellis Pharmaceuticals
APLS
16,81 €
Share price
-1.86%
Change (1 day)
-65.25%
Change (1 year)
Categories
Revenue for Apellis Pharmaceuticals (APLS)
Revenue in 2024 (TTM): €0.72 Billion
According to Apellis Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is €0.69 Billion. an increase over the revenue in the year 2023 that were of €0.35 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Apellis Pharmaceuticals from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €0.75 B | 109.3% |
| 2023 | €0.35 B | 410.23% |
| 2022 | €70.31 M | 19.63% |
| 2021 | €58.77 M | -71.16% |
| 2020 | €0.20 B | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |